Product
  • Product
  • Supplier
  • Inquiry

    EN

    Home > Chemial News > Pharma News > Analysis of market scale and competition of China Biomedical Industrial Park

    Analysis of market scale and competition of China Biomedical Industrial Park

    Echemi 2020-07-13

    Introduction: China Biomedical Industrial Park is constantly developing with the development of advanced innovation development zones. In the early 1990s, the country made a strategic decision to accelerate the development of advanced innovative technology industries. As of the end of 2019, there were 193 biomedical industrial parks in China, accounting for 49.87%, mainly in Jiangsu, Shandong, and Guangdong. The cumulative number of biomedical industrial parks in the three places reached 40, accounting for 21% of the national total. The TOP10 distribution area of the biomedical industrial park is relatively scattered, and Shanghai Zhangjiang High-tech Industrial Development Zone ranks first.

    In recent years, the scale of the output value of my country's biomedical parks has been increasing year by year, with an average annual compound growth rate of 11%. The scale of the output value in 2019 is 2.2 trillion yuan. The vast majority of domestic biopharmaceutical park enterprises have weak innovation output, and only a few parks are actively applying for Class 1 new drugs.

    By the end of 2019, there were 193 biomedical industrial parks in my country, accounting for 49.87%

    According to statistics, as of the end of 2019, there were 168 national-level high-tech zones and 219 national-level economic and technological development zones, with a total of 387 national-level industrial parks. Among them, 193 take the bio-pharmaceutical industry as the key development direction, accounting for 49.87%.

    my country's top 100 biopharmaceutical industrial parks are mainly concentrated in Jiangsu, Shandong, and Guangdong. The cumulative number of biomedical industrial parks in the three places has reached 40, accounting for 21% of the national total.

    According to statistics, China's top 100 biopharmaceutical industrial parks are mainly concentrated in Jiangsu, Shandong, and Guangdong. The cumulative number of biomedical industrial parks in the three places has reached 40, accounting for 21% of the national total; the number of biomedical industrial parks in Hubei and Zhejiang is There are 6 bio-pharmaceutical industrial parks in Hunan, Jilin and Tianjin areas.

    2020 my country's biomedical industrial park TOP10 distribution area is relatively scattered, Shanghai Zhangjiang High-tech Industrial Development Zone ranks first

    According to CCID data, the TOP10 distribution areas of my country's biomedical industrial park in 2020 are relatively scattered. Shanghai Zhangjiang Hi-Tech Industrial Development Zone ranks first, Suzhou Industrial Park and Zhongguancun Science Park rank second and third respectively.

    The scale of the output value of my country's biomedical parks has been increasing year by year, with an average annual compound growth rate of 11%. The scale of the output value in 2019 is 2.2 trillion yuan

    From 2017 to 2019, the scale of the output value of my country's biopharmaceutical parks has been increasing year by year, with an average annual compound growth rate of 11%. In 2019, the scale of my country's biomedical park output value was 2.2 trillion yuan, an increase of 12.9% year-on-year. According to CCID data, the output value of my country's biomedical parks will reach 2.5 trillion yuan by 2020.

    The vast majority of domestic biopharmaceutical park companies have weak innovation output, and only a few parks are actively applying for Class 1 new drugs

    The vast majority of domestic biopharmaceutical park enterprises have weak innovation output, and only a few parks are actively applying for Class 1 new drugs. In 2019, there were only 11 parks with more than 10 class 1 new drug declarations, and there was a wide gap in the number of class 1 new drug declarations between the parks.

    The biopharmaceutical industrial parks with more outstanding new drug declarations in 2019 are mainly Suzhou Industrial Park, Shanghai Zhangjiang High-tech Industrial Development Zone and Lianyungang Economic and Technological Development Zone, with more than 60 declarations.

    Share to:
    Disclaimer: Echemi reserves the right of final explanation and revision for all the information.

    Scan the QR Code to Share

    Suggestions
    Email:
    Message:
    Send Message